BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 36369191)

  • 21. Radiomics Study for Predicting the Expression of PD-L1 and Tumor Mutation Burden in Non-Small Cell Lung Cancer Based on CT Images and Clinicopathological Features.
    Wen Q; Yang Z; Dai H; Feng A; Li Q
    Front Oncol; 2021; 11():620246. PubMed ID: 34422625
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Machine Learning Approach Using PET/CT-based Radiomics for Prediction of PD-L1 Expression in Non-small Cell Lung Cancer.
    Lim CH; Koh YW; Hyun SH; Lee SJ
    Anticancer Res; 2022 Dec; 42(12):5875-5884. PubMed ID: 36456151
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Non-invasive CT imaging biomarker to predict immunotherapy response in gastric cancer: a multicenter study.
    Huang W; Xiong W; Tang L; Chen C; Yuan Q; Zhang C; Zhou K; Sun Z; Zhang T; Han Z; Feng H; Liang X; Zhong Y; Deng H; Yu L; Xu Y; Wang W; Shen L; Li G; Jiang Y
    J Immunother Cancer; 2023 Nov; 11(11):. PubMed ID: 38179695
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predicting malnutrition in gastric cancer patients using computed tomography(CT) deep learning features and clinical data.
    Huang W; Wang C; Wang Y; Yu Z; Wang S; Yang J; Lu S; Zhou C; Wu E; Chen J
    Clin Nutr; 2024 Mar; 43(3):881-891. PubMed ID: 38377634
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A CT-based deep learning radiomics nomogram for predicting the response to neoadjuvant chemotherapy in patients with locally advanced gastric cancer: A multicenter cohort study.
    Cui Y; Zhang J; Li Z; Wei K; Lei Y; Ren J; Wu L; Shi Z; Meng X; Yang X; Gao X
    EClinicalMedicine; 2022 Apr; 46():101348. PubMed ID: 35340629
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation of CT parameters and PD-L1 expression status in gastric cancer.
    Xu M; Ren T; Deng J; Yang J; Lu T; Xi H; Yuan L; Zhang W; Zhou J
    Abdom Radiol (NY); 2024 Apr; 49(4):1320-1329. PubMed ID: 38436699
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integration of longitudinal deep-radiomics and clinical data improves the prediction of durable benefits to anti-PD-1/PD-L1 immunotherapy in advanced NSCLC patients.
    Farina B; Guerra ADR; Bermejo-Peláez D; Miras CP; Peral AA; Madueño GG; Jaime JC; Vilalta-Lacarra A; Pérez JR; Muñoz-Barrutia A; Peces-Barba GR; Maceiras LS; Gil-Bazo I; Gómez MD; Ledesma-Carbayo MJ
    J Transl Med; 2023 Mar; 21(1):174. PubMed ID: 36872371
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A cohort study using IL-6/Stat3 activity and PD-1/PD-L1 expression to predict five-year survival for patients after gastric cancer resection.
    Li XN; Peng YH; Yue W; Tao L; Zhang WJ
    PLoS One; 2022; 17(12):e0277908. PubMed ID: 36454780
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Utility of CT radiomics for prediction of PD-L1 expression in advanced lung adenocarcinomas.
    Yoon J; Suh YJ; Han K; Cho H; Lee HJ; Hur J; Choi BW
    Thorac Cancer; 2020 Apr; 11(4):993-1004. PubMed ID: 32043309
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CT Image-Based Radiomic Analysis for Detecting PD-L1 Expression Status in Bladder Cancer Patients.
    Cao Y; Zhu H; Li Z; Liu C; Ye J
    Acad Radiol; 2024 Mar; ():. PubMed ID: 38556431
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Can PD-L1 expression evaluated by biopsy sample accurately reflect its expression in the whole tumour in gastric cancer?
    Yamashita K; Iwatsuki M; Harada K; Koga Y; Kiyozumi Y; Eto K; Hiyoshi Y; Ishimoto T; Iwagami S; Baba Y; Miyamoto Y; Yoshida N; Komohara Y; Ajani JA; Baba H
    Br J Cancer; 2019 Jul; 121(3):278-280. PubMed ID: 31285589
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A radiomics nomogram analysis based on CT images and clinical features for preoperative Lauren classification in gastric cancer.
    Nie T; Liu D; Ai S; He Y; Yang M; Chen J; Yuan Z; Liu Y
    Jpn J Radiol; 2023 Apr; 41(4):401-408. PubMed ID: 36370327
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development and validation of a deep learning signature for predicting lymph node metastasis in lung adenocarcinoma: comparison with radiomics signature and clinical-semantic model.
    Ma X; Xia L; Chen J; Wan W; Zhou W
    Eur Radiol; 2023 Mar; 33(3):1949-1962. PubMed ID: 36169691
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A multicenter study on the preoperative prediction of gastric cancer microsatellite instability status based on computed tomography radiomics.
    Liang X; Wu Y; Liu Y; Yu D; Huang C; Li Z
    Abdom Radiol (NY); 2022 Jun; 47(6):2036-2045. PubMed ID: 35391567
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radiomic and clinical data integration using machine learning predict the efficacy of anti-PD-1 antibodies-based combinational treatment in advanced breast cancer: a multicentered study.
    Zhao J; Sun Z; Yu Y; Yuan Z; Lin Y; Tan Y; Duan X; Yao H; Wang Y; Liu J
    J Immunother Cancer; 2023 May; 11(5):. PubMed ID: 37217246
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Deep learning-based radiomics predicts response to chemotherapy in colorectal liver metastases.
    Wei J; Cheng J; Gu D; Chai F; Hong N; Wang Y; Tian J
    Med Phys; 2021 Jan; 48(1):513-522. PubMed ID: 33119899
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development and external validation of a non-invasive imaging biomarker to estimate the microsatellite instability status of gastric cancer and its prognostic value: The combination of clinical and quantitative CT-imaging features.
    Zhao H; Gao J; Bai B; Wang R; Yu J; Lu H; Cheng M; Liang P
    Eur J Radiol; 2023 May; 162():110719. PubMed ID: 36764010
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predicting EGFR and PD-L1 Status in NSCLC Patients Using Multitask AI System Based on CT Images.
    Wang C; Ma J; Shao J; Zhang S; Liu Z; Yu Y; Li W
    Front Immunol; 2022; 13():813072. PubMed ID: 35250988
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The "digital biopsy" in non-small cell lung cancer (NSCLC): a pilot study to predict the PD-L1 status from radiomics features of [18F]FDG PET/CT.
    Monaco L; De Bernardi E; Bono F; Cortinovis D; Crivellaro C; Elisei F; L'Imperio V; Landoni C; Mathoux G; Musarra M; Pagni F; Turolla EA; Messa C; Guerra L
    Eur J Nucl Med Mol Imaging; 2022 Aug; 49(10):3401-3411. PubMed ID: 35403860
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deep learning radio-clinical signatures for predicting neoadjuvant chemotherapy response and prognosis from pretreatment CT images of locally advanced gastric cancer patients.
    Hu C; Chen W; Li F; Zhang Y; Yu P; Yang L; Huang L; Sun J; Chen S; Shi C; Sun Y; Ye Z; Yuan L; Chen J; Wei Q; Xu J; Xu H; Tong Y; Bao Z; Huang C; Li Y; Du Y; Xu Z; Cheng X
    Int J Surg; 2023 Jul; 109(7):1980-1992. PubMed ID: 37132183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.